Appointment booking for Dr. Gopika Chandra, MD is currently not available.Dr. Gopika Chandra, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Gopika Chandra, MD (she/her) is a Internist in Chicago, IL with over 13 years of experience. What is your opinion of Dr. Gopika Chandra, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 13 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Gopika Chandra, MD has received over $691 which includes payments from the following companies:
$120.22 from Janssen Pharmaceuticals, Inc
$80.70 from sanofi-aventis U.S. LLC
$63.53 from GlaxoSmithKline, LLC.
$50.89 from Orexo US, Inc.
$50.67 from Merck Sharp & Dohme Corporation
$44.91 from Pfizer Inc.
$40.15 from Astellas Pharma US Inc
$36.54 from E.R. Squibb & Sons, L.L.C.
$32.80 from Shire North American Group Inc
$24.01 from Amgen Inc.
$22.30 from Alkermes, Inc.
$20.56 from AstraZeneca Pharmaceuticals LP
$17.74 from LILLY USA, LLC
$17.21 from Endo Pharmaceuticals Inc.
$15.18 from Allergan Inc.
$15.16 from Ironwood Pharmaceuticals, Inc
$14.49 from Valeant Pharmaceuticals North America LLC
$13.93 from Kaleo, Inc.
$10.91 from Boehringer Ingelheim Pharmaceuticals, Inc.
Payments received by Dr. Gopika Chandra, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!